Answers are grounded in this paper and cite their sources.
Objectives Pediatric acute liver failure (PALF) is a rapidly progressive, life-threatening condition with heterogeneous causes and challenging treatment decisions. This study aimed to describe the etiological spectrum and clinical outcomes of PALF and summarize outcomes after auxiliary partial orthotopic liver transplantation (APOLT). Methods This retrospective single-center cohort study included 86 children with PALF treated at Beijing Friendship Hospital between November 2016 and April 2026. Clinical characteristics, etiologies, survival, and liver-transplantation outcomes were reviewed. Liver-tissue metagenomic next-generation sequencing (mNGS) was performed in children with indeterminate PALF. APOLT recipients were evaluated for survival, immunosuppression withdrawal, and available longitudinal histopathological findings. Results Indeterminate PALF was the most common etiology (43/86, 50.0%), followed by genetic or metabolic disorders (19/86, 22.1%) and drug-induced liver injury (14/86, 16.3%). Viral sequences were detected by liver-tissue mNGS in 24 of 26 children (92.3%) with indeterminate PALF. HHV-6 was detected in 23, including 5 with HHV-6 as the only viral finding and 18 with viral co-detections. Liver transplantation was performed in 49 children (57.0%); estimated survival in the transplantation group was 83%, 77%, and 73% at 1, 3, and 12 months, respectively. Among 22 APOLT recipients, 15 (68.2%) survived. Eleven of the 15 survivors (73.3%) had completely discontinued immunosuppression by the last follow-up. Serial histopathology in 15 recipients showed variable native-liver recovery and acute cellular rejection in some graft biopsies. Conclusion Indeterminate PALF was common, and HHV-6 was frequently detected in liver tissue from this subgroup. However, viral detection alone does not establish causation. Liver transplantation was associated with better observed survival among children with severe PALF, while APOLT offered the possibility of native-liver recovery and immunosuppression withdrawal in selected survivors. Long-term monitoring of both the native liver and graft remains important.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: